搜索临床试验以:Placebo to BI 113608 low dose b.i.d.
总计838个结果
-
University of OxfordMedical Research Council终止
-
Precigen Actobio T1D, LLCTFS Trial Form Support; Intrexon Actobiotics NV, d/b/a Precigen Actobio完全的
-
Newron Pharmaceuticals SPA终止
-
PfizerAthersys, Inc完全的
-
Siena Biotech S.p.A.Seventh Framework Programme; European Huntington's Disease Network完全的
-
Mead Johnson NutritionNorth Shore Research Institue完全的
-
Celon Pharma SANational Center for Research and Development, Poland招聘中
-
SamA Pharmaceutical Co., Ltd完全的
-
SK Chemicals Co., Ltd.完全的Non-constipation Irritable Bowel Syndrome大韩民国
-
AllerganMAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan完全的
-
Boehringer IngelheimEli Lilly and Company完全的
-
University of Missouri-ColumbiaNational Center for Complementary and Integrative Health (NCCIH); Office of Dietary Supplements...完全的
-
Boehringer Ingelheim完全的